Adverse effects of oral naltrexone: analysis of data from two clinical trials

Overview of attention for article published in Psychopharmacology, April 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

policy: 2 policy sources

patent: 13 patents

Citations

dimensions_citation: 71 Dimensions

Readers on

mendeley: 48 Mendeley

Summary Policy documents Patents Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Nalmefene for reducing alcohol consumption in people with alcohol dependence: Evaluation report

Cited by National Institute for Health and Care Excellence on 09 Jul 2014

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Injectable Extended-Release Naltrexone to Treat Opioid Use Disorder

Cited by Canadian Agency for Drugs and Technologies in Health on 31 May 2011

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.